Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
784.00    -6.00 (-0.76%)
Bid:
780.00
Ask:
796.00
Spread: 16.00 (2.051%)
Market Cap: £361.39m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM/Interim Management Statement

13 Apr 2010 07:00

RNS Number : 0520K
Porvair PLC
13 April 2010
 



FOR IMMEDIATE RELEASE

13 April 2010

 

Porvair plc

AGM Statement and Interim Management Statement

 

Porvair plc ("Porvair"), the specialist filtration and environmental technology group will today, 13 April 2010, make the following Interim Management Statement at its Annual General Meeting:

 

Porvair has made an encouraging start to the 2010 financial year. In the four months to 31 March 2010, profit before tax is well ahead of the prior year. Current net borrowings are £3.3m lower than the equivalent time last year. At constant exchange rates, revenues are around 5% higher than the prior period, with recovery or continued growth in most markets offset by expected modest declines in aerospace filtration sales.

 

In the Metals Filtration division sales revenues are 13% higher than the prior period. This business has a lower cost base following its 2009 restructuring and as a result profitability is better. It should be noted that whilst levels of demand in 2010 have improved, they remain below those of 2004-2008 and management continue to look at projects that will boost the underlying performance of this division. Key to this will be the sustained success of new products, which continue to go well. 85% of the division's aluminium customers have now converted to the patented Selee CS-X™ filter. Upgrades have been introduced in recent weeks that further enhance this market leading product in the aluminium industry. In the iron foundry industry, a similarly exciting new product, the patented Selee IC™ filter, has now been adopted by several leading automotive and agricultural machinery manufacturers in the US.

 

In the Microfiltration division sales revenues are slightly ahead of the prior year. Seal Analytical has made a strong start with improved sales in the US and Europe and continuing strength in Asia helped by the introduction of the Seal Analytical AQ1™ water analyser in February 2010. The division is seeing satisfactory levels of demand in energy and nuclear filtration where several larger orders are scheduled for delivery later in the year. Growth in this division's US industrial filtration business has been robust. This is offset by a decline in aerospace schedules compared with a strong opening quarter of the prior year. Aerospace sales in 2010 are at similar levels to the second half of 2009 with run rates and order schedules showing modest improvements over the last three months.

 

The Company will be announcing its interim results for the six months ending 31 May 2010 on Tuesday 29 June 2010.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Catherine Breen

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSFLFLEFSSEDL
Date   Source Headline
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.